{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:22:20Z","timestamp":1792196540373,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T00:00:00Z","timestamp":1461888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s10194-016-0638-5","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T01:42:16Z","timestamp":1461894136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Altered kynurenine pathway metabolites in serum of chronic migraine patients"],"prefix":"10.1186","volume":"17","author":[{"given":"Martina","family":"Curto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Lionetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Negro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Capi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Adele","family":"Giamberardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Simmaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Martelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,29]]},"reference":[{"key":"638_CR1","first-page":"15","volume":"28","author":"P Martelletti","year":"2014","unstructured":"Martelletti P, Katsarava Z, Lampl C, Magis D, Bendtsen L, Negro A, Russell MB, Mitsikostas DD, Jensen RH (2014) Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation. J Headache Pain 28:15\u20134","journal-title":"J Headache Pain"},{"key":"638_CR2","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1007\/s11739-010-0457-7","volume":"5","author":"A Negro","year":"2010","unstructured":"Negro A, D'Alonzo L, Martelletti P (2010) Chronic migraine: comorbidities, risk factors, and rehabilitation. Intern Emerg Med 5:S13\u20139","journal-title":"Intern Emerg Med"},{"key":"638_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10194-011-0342-4","volume":"12","author":"TJ Steiner","year":"2011","unstructured":"Steiner TJ, Birbeck GL, Jensen R, Katsarava Z, Martelletti P, Stovner LJ (2011) The Global Campaign, World Health Organization and Lifting The burden: collaboration in action. J Headache Pain 12:273\u20134","journal-title":"J Headache Pain"},{"key":"638_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10194-012-0460-7","volume":"13","author":"LM Bloudek","year":"2012","unstructured":"Bloudek LM, Stokes M, Buse DC, Wilcox TK, Lipton RB, Goadsby PJ, Varon SF, Blumenfeld AM, Katsarava Z, Pascual J, Lanteri-Minet M, Cortelli P, Martelletti P (2012) Cost of healthcare for patients with migraine in five European countries: results fromthe International Burden of Migraine Study (IBMS). J Headache Pain 13:361\u201378","journal-title":"J Headache Pain"},{"key":"638_CR5","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","volume":"380","author":"M Vos","year":"2012","unstructured":"Vos M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V et al (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2163\u201396","journal-title":"Lancet"},{"key":"638_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1129-2377-14-1","volume":"14","author":"TJ Steiner","year":"2013","unstructured":"Steiner TJ, Stovner LJ, Birbeck GL (2013) Migraine: the seventh disabler. J Headache Pain 14:1","journal-title":"J Headache Pain"},{"key":"638_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1517\/14728214.2012.709846","volume":"17","author":"L Lionetto","year":"2012","unstructured":"Lionetto L, Negro A, Palmisani S, Gentile G, Del Fiore MR, Mercieri M, Simmaco M, Smith T, Al-Kaisy A, Arcioni R, Martelletti P (2012) Emerging treatment for chronic migraine and refractory chronic migraine. Expert Opin Emerg Drugs 17:393\u2013406","journal-title":"Expert Opin Emerg Drugs"},{"key":"638_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nrd3793","volume":"12","author":"L V\u00e9csei","year":"2013","unstructured":"V\u00e9csei L, Szal\u00e1rdy L, F\u00fcl\u00f6p F, Toldi J (2013) Kynurenines in the CNS: recent advances and new questions. Nat Rev Drug Discov 12:64\u201382","journal-title":"Nat Rev Drug Discov"},{"key":"638_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11916-007-0216-2","volume":"11","author":"P Sarchielli","year":"2007","unstructured":"Sarchielli P, Di Filippo M, Nardi K, Calabresi P (2007) Sensitization, glutamate, and the link between migraine and fibromyalgia. Curr Pain Headache Rep 11:343\u201351","journal-title":"Curr Pain Headache Rep"},{"key":"638_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2174\/187152707781387279","volume":"6","author":"M Vikelis","year":"2007","unstructured":"Vikelis M, Mitsikostas DD (2007) The role of glutamate and its receptors in migraine. CNS Neurol Disord Drug Targets 6:251\u20137","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"638_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrn3770","volume":"15","author":"D Pietrobon","year":"2014","unstructured":"Pietrobon D, Moskowitz MA (2014) Chaos and commotion in the wake of cortical spreading depression and spreading depolarizations. Nat Rev Neurosci 15:379\u201393","journal-title":"Nat Rev Neurosci"},{"key":"638_CR12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nrneurol.2013.192","volume":"9","author":"AC Charles","year":"2013","unstructured":"Charles AC, Baca SM (2013) Cortical spreading depression and migraine. Nat Rev Neurol 9:637\u201344","journal-title":"Nat Rev Neurol"},{"key":"638_CR13","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/ng.652","volume":"42","author":"V Anttila","year":"2010","unstructured":"Anttila V, Stefansson H, Kallela M, Todt U, Terwindt GM et al (2010) International Headache Genetics Consortium. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet 42:869\u201373","journal-title":"Nat Genet"},{"key":"638_CR14","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/ejhg.2011.48","volume":"19","author":"L Ligthart","year":"2011","unstructured":"Ligthart L, de Vries B, Smith AV, Ikram MA, Amin N, Hottenga JJ, Koelewijn SC et al (2011) Meta-analysis of genome-wide association for migraine in six population-based European cohorts. Eur J Hum Genet 19:901\u20137","journal-title":"Eur J Hum Genet"},{"issue":"43","key":"638_CR15","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/ng.856","volume":"12","author":"DI Chasman","year":"2011","unstructured":"Chasman DI, Sch\u00fcrks M, Anttila V, de Vries B, Schminke U, Launer LJ, Terwindt GM et al (2011) Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet 12(43):695\u20138","journal-title":"Nat Genet"},{"key":"638_CR16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1468-2982.2004.00750.x","volume":"24","author":"MF Peres","year":"2004","unstructured":"Peres MF, Zukerman E, Senne Soares CA, Alonso EO, Santos BF, Faulhaber MH (2004) Cerebrospinal fluid glutamate levels in chronic migraine. Cephalalgia 24:735\u20139","journal-title":"Cephalalgia"},{"key":"638_CR17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1046\/j.1468-2982.1995.015002132.x","volume":"15","author":"AR Cananzi","year":"1995","unstructured":"Cananzi AR, D'Andrea G, Perini F, Zamberlan F, Welch KM (1995) Platelet and plasma levels of glutamate and glutamine in migraine with and without aura. Cephalalgia 15:132\u20135","journal-title":"Cephalalgia"},{"key":"638_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s10194-015-0581-x","volume":"16","author":"A Cs\u00e1ti","year":"2015","unstructured":"Cs\u00e1ti A, Edvinsson L, V\u00e9csei L, Toldi J, F\u00fcl\u00f6p F, Tajti J, Warfvinge K (2015) Kynurenic acid modulates experimentally induced inflammation in the trigeminal ganglion. J Headache Pain 16:99","journal-title":"J Headache Pain"},{"key":"638_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrn3257","volume":"13","author":"R Schwarcz","year":"2012","unstructured":"Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13:465\u201377","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"638_CR20","doi-asserted-by":"publisher","first-page":"17799","DOI":"10.1038\/srep17799","volume":"8","author":"F Fazio","year":"2015","unstructured":"Fazio F, Lionetto L, Curto M, Iacovelli L, Cavallari M, Zappulla C, Ulivieri M, Napoletano F, Capi M, Corigliano V, Scaccianoce S, Caruso A, Miele J, De Fusco A, Di Menna L, Comparelli A, De Carolis A, Gradini R, Nistic\u00f2 R, De Blasi A, Girardi P, Bruno V, Battaglia G, Nicoletti F, Simmaco M (2015) Xanthurenic Acid Activates mGlu2\/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia. Sci Rep 8(5):17799","journal-title":"Sci Rep"},{"key":"638_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuropharm.2014.02.011","volume":"81","author":"F Fazio","year":"2014","unstructured":"Fazio F, Zappulla C, Notartomaso S, Busceti C, Bessede A, Scarselli P, Vacca C, Gargaro M, Volpi C, Allegrucci M, Lionetto L, Simmaco M, Belladonna ML, Nicoletti F, Fallarino F (2014) Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice. Neuropharmacology 81:237\u201343","journal-title":"Neuropharmacology"},{"key":"638_CR22","first-page":"981","volume":"16","author":"G Ol\u00e0h","year":"2013","unstructured":"Ol\u00e0h G, Her\u00e9di J, Menyh\u00e0rt A, Czinege Z, Nagy D, Fuzik J, Kocsis K, Knapp L, Krucs\u00f2 E, Gell\u00e9rt L, Kis Z, Farkas T, Fulop F, P\u00e0rdutz A, Tajti J, V\u00e9csei L, Toldi J (2013) Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood\u2013brain barrier permeability. Drug Des Devel Ther 16:981\u20137","journal-title":"Drug Des Devel Ther"},{"key":"638_CR23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.expneurol.2003.12.001","volume":"186","author":"E Knyih\u00e1r-Csillik","year":"2004","unstructured":"Knyih\u00e1r-Csillik E, Chadaide Z, Okuno E, Krisztin-P\u00e9va B, Toldi J, Varga C, Moln\u00e1r A, Csillik B, V\u00e9csei L (2004) Kynurenine aminotransferase in the supratentorial dura mater of the rat: effect of stimulation of the trigeminal ganglion. Exp Neurol 186:242\u20137","journal-title":"Exp Neurol"},{"key":"638_CR24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00702-006-0545-z","volume":"114","author":"E Knyihar-Csillik","year":"2007","unstructured":"Knyihar-Csillik E, Toldi J, Mih\u00e1ly A, Krisztin-P\u00e9va B, Chadaide Z, N\u00e9meth H, Fenyo R, V\u00e9csei L (2007) Kynurenine in combination with probenecid mitigates the stimulation-induced increase of c-fos immunoreactivity of the rat caudal trigeminal nucleus in an experimental migraine model. J Neural Transm 114:417\u201321","journal-title":"J Neural Transm"},{"key":"638_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.neulet.2007.03.007","volume":"418","author":"E Knyihar-Csillik","year":"2007","unstructured":"Knyihar-Csillik E, Toldi J, Krisztin-P\u00e9va B, Chadaide Z, N\u00e9meth H, Fenyo R, V\u00e9csei L (2007) Prevention of electrical stimulation-induced increase of c-fos immunoreaction in the caudal trigeminal nucleus by kynurenine combined with probenecid. Neurosci Lett 418:122\u20136","journal-title":"Neurosci Lett"},{"key":"638_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.neures.2008.04.009","volume":"61","author":"E Knyihar-Csillik","year":"2008","unstructured":"Knyihar-Csillik E, Mihaly A, Krisztin-Peva B, Robotka H, Szatmari I, Fulop F, Toldi J, Csillik B, Vecsei L (2008) The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus: comparative studies of the effects of SZR-72 and kynurenic acid. Neurosci Res 61:429\u201332","journal-title":"Neurosci Res"},{"key":"638_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.neuropharm.2009.06.033","volume":"57","author":"E Vamos","year":"2009","unstructured":"Vamos E, P\u00e1rdutz A, Varga H, Boh\u00e1r Z, Tajti J, F\u00fcl\u00f6p F, Toldi J, V\u00e9csei L (2009) L-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus. Neuropharmacology 57:425\u20139","journal-title":"Neuropharmacology"},{"key":"638_CR28","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/j.1526-4610.2009.01574.x","volume":"50","author":"E Vamos","year":"2010","unstructured":"Vamos E, Fejes A, Koch J, Tajti J, F\u00fcl\u00f6p F, Toldi J, P\u00e1rdutz A, V\u00e9csei L (2010) Kynurenate derivative attenuates the nitroglycerin-induced CamKII\u03b1 and CGRP expression changes. Headache 50:834\u201343","journal-title":"Headache"},{"key":"638_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.expneurol.2012.05.002","volume":"236","author":"V Chauvel","year":"2012","unstructured":"Chauvel V, Vamos E, Pardutz A, Vecsei L, Schoenen J, Multon S (2012) Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat. Exp Neurol 236:207\u201314","journal-title":"Exp Neurol"},{"issue":"8","key":"638_CR30","doi-asserted-by":"publisher","first-page":"e82279","DOI":"10.1371\/journal.pone.0082279","volume":"10","author":"V Chauvel","year":"2013","unstructured":"Chauvel V, Schoenen J, Multon S (2013) Influence of ovarian hormones on cortical spreading depression and its suppression by L-kynurenine in rat. PLoS ONE 10(8):e82279","journal-title":"PLoS ONE"},{"key":"638_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/npp.2011.181","volume":"37","author":"B Moghaddam","year":"2012","unstructured":"Moghaddam B, Javitt D (2012) From revolution to evolution: the glutamatergic hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacol 37:4\u201315","journal-title":"Neuropsychopharmacol"},{"key":"638_CR32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","volume":"72","author":"TW Stone","year":"1981","unstructured":"Stone TW, Perkins MN (1981) Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur J Pharmacol 72:411\u20132","journal-title":"Eur J Pharmacol"},{"key":"638_CR33","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0028-3908(98)00080-X","volume":"37","author":"RD Bartlett","year":"1998","unstructured":"Bartlett RD, Esslinger CS, Thompson CM, Bridges RJ (1998) Substituted quinolines as inhibitors of L-Glutamate transport into synaptic vesicles. Neuropharmacology 37:839\u201346","journal-title":"Neuropharmacology"},{"key":"638_CR34","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/npp.2013.4","volume":"38","author":"SA Neale","year":"2013","unstructured":"Neale SA, Copeland CS, Uebele VN, Thomson FJ, Salt TE (2013) Modulation of hippocampal synaptic transmission by the kynurenine pathway member xanthurenic acid and other VGLUT inhibitors. Neuropsychopharmacol 38:1060\u20137","journal-title":"Neuropsychopharmacol"},{"key":"638_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tips.2009.12.003","volume":"31","author":"S Chiechio","year":"2010","unstructured":"Chiechio S, Copani A, Zammataro M, Battaglia G, Gereau RW 4th, Nicoletti F (2010) Transcriptional regulation of type-2 metabotropic glutamate receptors: an epigenetic path to novel treatments for chronic pain. Trends Pharmacol Sci 31:153\u201360","journal-title":"Trends Pharmacol Sci"},{"key":"638_CR36","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.neuropharm.2010.10.022","volume":"60","author":"F Nicoletti","year":"2011","unstructured":"Nicoletti F, Bockaert J, Collingridge GL, Conn PJ, Ferraguti F, Schoepp DD, Wroblewski JT, Pin JP (2011) Metabotropic glutamate receptors: from the workbench to the bedside. Neuropharmacology 60:1017\u201341","journal-title":"Neuropharmacology"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s10194-016-0638-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-016-0638-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-016-0638-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-016-0638-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T12:08:46Z","timestamp":1553602126000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-016-0638-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,29]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["638"],"URL":"https:\/\/doi.org\/10.1186\/s10194-016-0638-5","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,29]]},"article-number":"47"}}